News

The International Association for the Study of Lung Cancer (IASLC) seeks a Vendor to produce a daily “newspaper” during each day of its annual world conference.

IASLC Newsletter - March 2018

Immunotherapy has recently emerged as a new treatment modality in lung cancer, and reactivating immune responses that are silenced by immune checkpoints is an idea that has recently gained a lot of interest.

The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced that the 2018 Heine H. Hansen (HHH) Award will be given to Fabrice Barlesi.

Around 2,300 participants from across the world will meet in Geneva at the eighth European Lung Cancer Congress (ELCC 2018, 11-14 April 2018) to learn about and discuss the latest research in the field of lung cancer.

The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated solely to advancing the education and understanding of lung cancer and other thoracic malignancies, is sponsoring its first major educational conference in Africa.

Given the sensitive nature of many of the presentations at this meeting, your adherence to our social media policy is requested.

Pages